HomeCEROW • NASDAQ
add
CERo Therapeutics Holdings
Previous close
$0.020
Year range
$0.013 - $0.25
Market cap
2.88M USD
Avg Volume
14.50K
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 4.55M | 86.69% |
Net income | -2.30M | 5.69% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.44M | -91.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 4.59M | 2,479.05% |
Total assets | 9.05M | -37.27% |
Total liabilities | 13.03M | -49.89% |
Total equity | -3.98M | — |
Shares outstanding | 15.06M | — |
Price to book | -0.02 | — |
Return on assets | -129.22% | — |
Return on capital | 161.89% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.30M | 5.69% |
Cash from operations | -5.08M | -253.60% |
Cash from investing | — | — |
Cash from financing | 7.16M | 138,428.47% |
Net change in cash | 2.08M | 245.14% |
Free cash flow | 11.93M | 1,248.61% |
About
Founded
2020
Headquarters
Website
Employees
8